Ann: Updated Use of Funds, page-7

Below is the timeline of events

Can anyone tell me who in the Board of Directors (past and present ) and Management team (past and present) is individually responsible for each of these achievements (progress)?
IMO it is a team effort. The core team has not changed a great deal since the float although their roles have changed as we know. Radford is a new appointment along with Xu. Hamish Macdonald (previous CEO) still a Director who participated in the recent SPP together with Mutton and Wallace. I note Beasley did not participate. Beehag is on the way out.

We need a cohesive team running THC.

Will we have that with Beasley who is kicking out the majority of the team that are responsible for the Company’s achievements to date. Who will he appoint as CEO, CFO etc. how long will it take for the new team to settle in and work out the direction they will take the Company? Competition in this sector is fierce with many players claiming first mover advantage. We need a team that is on top of the game!

Who is the best team? The team with a track record or the unknown newly appointed team?

This is a very critical time for this Company and unity at the top is key.
Remember every year we have a chance to review our decisions at the AGM



Is someone able to contact Hamish Macdonald or Wallace and get the inside story from them?

THE HYDROPONICS COMPANY TIMELINE
NEWSWIRE
THE HYDROPONICS COMPANY DIRECTORS PROVIDE VOTE OF CONFIDENCE IN MEDICINAL CANNABIS STRATEGY
February 02 2018
Three directors participate in oversubscribed share purchase plan.
ARTICLE
THE HYDROPONICS COMPANY ASSESSES CANADIAN ENTITY WITH C$20 MILLION A YEAR IN REVENUES
January 24 2018
Management is assessing further acquisition opportunities and organic growth initiatives.
NEWSWIRE
THE HYDROPONICS COMPANY FORCED TO SCALE BACK SHARE PURCHASE PLAN
January 22 2018
Funds raised through the share purchase plan will drive growth in Australia and Canada.
NEWSWIRE
THE HYDROPONICS COMPANY POSITIONS ITSELF TO TAKE ADVANTAGE OF AUSTRALIAN MARKET
January 16 2018
Changes to regulations in Australia have opened the door for cannabis breeders.
NEWSWIRE
THE HYDROPONICS COMPANY APPOINTS FINANCE SPECIALIST AS DIRECTOR
January 15 2018
The new appointment has experience with investments in medicinal cannabis.
NEWSWIRE
THE HYDROPONICS COMPANY RAISING $3 MILLION FOR MEDICINAL CANNABIS
January 08 2018
The company is preparing to start a pilot cannabis growing program.
ARTICLE
THE HYDROPONICS COMPANY GETS A LIFT FOLLOWING MEDICINAL CANNABIS EXPORT APPROVAL
January 05 2018
On track for a pilot cannabis growing program targeted for first half of 2018.
NEWSWIRE
THE HYDROPONICS COMPANY ATTRACTS INVESTMENT FROM INTERNATIONAL FUND
December 28 2017
THC's shares have soared 16% to $0.73 in early trade.
NEWSWIRE
THE HYDROPONICS COMPANY TO SELL UNIQUE LIGHTING PRODUCTS FOR THE CANNABIS MARKET
December 21 2017
This exclusive distribution contract adds to the portfolio of products marketed in Canada.
ARTICLE
THE HYDROPONICS COMPANY RAISES $8 MILLION TO FAST-TRACK DEVELOPMENT OF MEDICINAL CANNABIS IN AUSTRAL
December 14 2017
Seven new institutional investors have joined the company’s register.
NEWSWIRE
THE HYDROPONICS COMPANY TO LIFT FUNDS FOR NEXT MEDICAL CANNABIS STEPS
December 12 2017
The halt will remain in place until Thursday 14th December 2017.
ARTICLE
THE HYDROPONICS COMPANY ENTERS LICENCING AGREEMENT WITH CANADIAN LEADER
December 07 2017
Shares have rallied 15% intra-day, currently priced at $0.85.
NEWSWIRE
THE HYDROPONICS COMPANY ADVANCES MEDICAL CANNABIS STRATEGY AS SHARES RELEASED FROM ESCROW
November 30 2017
The company has a clear strategy for bringing medicinal cannabis to the Australian market.
NEWSWIRE
THE HYDROPONICS COMPANY MAKES KEY APPOINTMENT FOLLOWING MEDICAL CANNABIS PARTNERSHIP
November 21 2017
Debbie Ormsby will lead Canndeo to fast-track medicinal cannabis products into Australia.
ARTICLE
THE HYDROPONICS COMPANY IN COMPANY MAKING PARTNERSHIP WITH ISRAEL'S BOL PHARMA
November 20 2017
BOL Pharma sources 99% pure pharma grade cannabinoids from its own facility.
ARTICLE
THE HYDROPONICS COMPANY’S SHARES SURGE AFTER SIGNING MEDICINAL CANNABIS DEAL
November 15 2017
Initial products imported to Australia will include cannabidiol oil.
ARTICLE
THE HYDROPONICS COMPANY GRANTED MEDICINAL CANNABIS LICENCE
October 30 2017
Canndeo Ltd operates under a pharmaceutical model.
NEWSWIRE
THE HYDROPONICS COMPANY MAKES KEY MANAGEMENT CHANGES
October 19 2017
David Radford has been appointed as the new chief executive officer.
ARTICLE
THE HYDROPONICS COMPANY IDENTIFIES POTENTIAL INTERNATIONAL MEDICAL CANNABIS PARTNERS
September 05 2017
The company has engaged with potential European and Israeli partners.
ARTICLE
THE HYDROPONICS COMPANY ENTERS PARTNERSHIP FACILITATED AT DISPENSING MEDICINAL CANNABIS
September 01 2017
The Hydroponics Company is developing a diversified worldwide cannabis business.
ARTICLE
THE HYDROPONICS COMPANY REFLECTS ON STRONG FIRST QUARTER ON THE ASX
August 02 2017
Since listing on the ASX in May 2017, the company has increased its number of shareholders by 240%.
ARTICLE
THE HYDROPONICS COMPANY DETAILS DOMESTIC MEDICINAL CANNABIS PRODUCTION
July 13 2017
Canndeo is building a domestic medicinal cannabis production and supply capability.
ARTICLE
THE HYDROPONICS COMPANY LTD GRANTED A CANNABIS RESEARCH LICENCE
July 11 2017
The licence allows Canndeo to build its exclusive Plant Breeders Rights.
NEWSWIRE
THE HYDROPONICS COMPANY LTD PREPARES FOR LICENCE DECISION
July 07 2017
Canndeo is well positioned to benefit from recent regulatory changes.
NEWSWIRE
THE HYDROPONICS COMPANY ADVANCES AUSTRALIAN SOLUTION
June 20 2017
Canndeo is well positioned to benefit from recent regulatory changes.
ARTICLE
THE HYDROPONICS COMPANY ENTERS STRATEGIC ALLIANCE
May 24 2017
Canndeo is a wholly owned subsidiary of The Hydroponics Company.
NEWSWIRE
THE HYDROPONICS COMPANY TO REVEAL STRATEGIC ALLIANCE
May 23 2017
The halt will remain in place until Thursday 25th May 2017.